Drugs@FDA document
ABACAVIR SULFATE AND LAMIVUDINE Label · NDA 204311 ORIG-1
Drugs@FDA document · PHARMOBEDIENT · Dec 27, 2023
Key facts
| Drug name | ABACAVIR SULFATE AND LAMIVUDINE |
|---|---|
| Document type | Label |
| Application | NDA204311 |
| Submission | ORIG-1 |
| Company | PHARMOBEDIENT |
| Document date | Dec 27, 2023 |
| FDA document | accessdata.fda.gov |
At a glance
- 10–99 Documents for this application
- 1–9 USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: